Dublin, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications:
- Infectious Disease Testing
- Blood Screening
- Cancer Screening
- Other Applications
The report profiles 145 companies including many key and niche players such as
- Abbott Laboratories (US)
- Abbott Molecular, Inc. (US)
- Becton, Dickinson and Company (US)
- bioMérieux SA (France)
- Cepheid (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- RMD's Product Portfolio by Segment
- RMD's Major Test Offerings by Application
- GE Healthcare (US)
- Grifols International, S.A. (Spain)
- Hologic, Inc. (US)
- QIAGEN N.V. (The Netherlands)
- Quest Diagnostics, Inc. (US)
- Siemens Healthcare GmBH (Germany)
- Tecan Group Ltd. (Switzerland)
- The ELITechGroup SAS (France)
- Thermo Fisher Scientific (US)
Key Topics Covered: 1. OUTLOOK Global In-Vitro Diagnostics (IVD) Market on a Steady Growth Path Molecular Diagnostics A Rapidly Expanding Segment of the IVD Market PCR Technology Leads the MDx Market Current and Future Analysis US and Europe Leaders in Molecular Diagnostics Adoption Developing Countries Excel in Growth Prospects Major Growth Drivers Key Market Trends in a Nutshell Major Technology Trends Advancements in Molecular Diagnostics A Boon for the Industry Major Issues and Challenges Market Outlook 2. GROWTH DRIVERS AND MARKET TRENDS Aging Population Drives Molecular Diagnostics Market Global Aging Population Statistics Opportunity Indicators Technological Innovations Set to Drive the Market The Role of Molecular Diagnostics in Personalized Medicine Companion Diagnostics Make Way for Personalized Medicine List of Select FDA-Cleared Companion Diagnostic Devices Biomarkers as Companion Diagnostics Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth Proteomics Technologies: Growing in Significance New Developments in Proteomics Technologies New Applications Hold Promising Potential Molecular Diagnostics for Lymphoid Malignancies Next-Generation Sequencing Technologies Keep Up the Momentum Select Commercial NGS Technologies Rising Emphasis on Lab Automation to Augur Well for Market Growth List of Fully Automated and Rapid Molecular Diagnostics Molecular Diagnostics and Intellectual Property Molecular Diagnostics Moving from Centralization to Decentralization Limited Reimbursements by Third Party Payers A Stumbling Block 3. APPLICATION AREAS OF MOLECULAR DIAGNOSTICS Infectious Diseases Bright Prospects Ahead for Molecular Diagnostics for Testing Infectious Diseases Leading Players Key Trends Increasing Incidence of Infectious Diseases Fuels Adoption Rising Incidence of Hospital Acquired Infections Propels Market Growth Rising HIV Prevalence Provides Ample Growth Opportunities Infectious Disease Testing A Major Driver of Molecular Diagnostics Market Select FDA-Cleared Molecular Diagnostic Tests for Infectious Diseases Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market List of Select HPV Molecular Diagnostic Tests by Company and Technique Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing Major Risk Factors to HPV/Cervical Cancer HPV Testing for Primary Screening Indication Bodes Well for the Market's Growth Archaic TB Diagnostic Methods Opens Up Opportunities for Molecular Diagnostics List of Select Commercially-Available TB Diagnostics An Overview of Select TB Diagnostics under Development Molecular POC Testing for Infectious Diseases: Yet to Realize Its Full Potential PCR Plays a Vital Role in the Diagnosis of Infectious Diseases Blood Screening Molecular based Tests Ingrain Roots in Blood Donor Screening Segment Cancer Screening & Diagnosis Overview Molecular Tests Lead the Way for Cancer IVD Market Growth Molecular Markers to Enhance Thyroid Cancer Diagnosis Oncology-Based Molecular Diagnostics: The Propitious Segment List of US-FDA Approved Biomarkers for Cancer Growing Popularity of Chemo-Sensitivity Testing of CTCs Cervical Cancer Screening: Focus on Detection of CIN2 and CIN3 Cancers Other Testing Applications Genetic Disease Testing Applications Overview Pharmacogenomics Prognosis Based on Genomics Pharmacogenomics Development Augurs Growth of Genetic Testing Market Prospects for Genetic Diagnostics and Testing Grow Brighter List of Select FDA-Cleared Genetic Tests by Disease Genetic Testing An Indispensible Tool for Cystic Fibrosis Genetic Testing Plays Pivotal Role in Diagnosing Inherited Conditions Non-Invasive Prenatal Diagnostics The Way Ahead Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents Histocompatibility Testing 4. COMPETITIVE DYNAMICS IN THE MOLECULAR DIAGNOSTICS MARKET An Overview of Competitive Landscape in Molecular Diagnostics Other Noteworthy Companies and their Competitive Position by Segment Key Players and Their Technologies The Top Tier Mid-Sized and Small Companies Cepheid: Unquestioned Leader in the Rapid and Automated MDx Market Qiagen: The Leading Player in the Global HPV MDx Market Comparative Analysis of Select HPV MDx Tests Competitive Dynamics in the C. difficile Testing Market List of Select Molecular C. difficile Test Products Competition in the Blood Screening MDx Market Pharmaceutical Firms Carving Their Niche in Molecular Diagnostic Market Competitive Landscape in the Global RT-PCR Market Thermo Fischer, Bio-Rad, Roche, Agilent, Qiagen and Others (includes corresponding Graph/Chart) Select Real-Time PCR Products by Company Competition Heats Up in dPCR Market Life Sciences Companies Eye on Lucrative Prostate Cancer MDx Market Consolidation Activity Continues to Strengthen Driven by New Entrants Major M&A Transactions in Molecular Diagnostics: 2011-2016 Product Marketing Key to Commercial Success 5. PRODUCT & TECHNOLOGY OVERVIEW Molecular Diagnostics Definition & Scope Molecular Diagnostics Impact on Healthcare Utility of Molecular Diagnostic Tests Background of Molecular Diagnostics Major Milestones in the Evolution of Molecular Diagnostics Types of Molecular Diagnostics Conventional Diagnostics Vs. Molecular Diagnostics Unabated Developments in Molecular Diagnostics Technology Signal Amplification Technologies PCR New Developments Quantitative Real-Time PCR for Molecular Diagnostics Signal Detection and Quantification Quantitative Real-Time RT-PCR Analysis Applications of Quantitative Real-Time PCR Analysis Digital PCR Non-PCR Methods Other Signal Amplification Technologies DNA Probe Based Products Direct Detection of Specific Nucleic Acid Sequences Nucleic Acid Amplification and Detection DNA Sequencing and Gene Detection Arrays of Immobilized Probes (DNA Chips) in Gene Detection RNA Diagnostics Complementary Molecular Diagnostic Technologies Fluorescent In-Situ Hybridization (FISH) DNA Biochips/Microarrays Biosensors Proteomic Technologies for Molecular Diagnostics Nanotechnology for Molecular Diagnostics Technologies on the Anvil Haplotype Analysis A Distant Possibility Chronic Multi-Gene Defects Now Diagnosable Whole Genome Sequencing A Boon or a Bane to Genetic Testing? 6. PRODUCT APPROVALS/INTRODUCTIONS Qiagen Introduces New Diagnostic Test for Cervical Cancer GE Showcases Discovery MI and Discovery NM/CT 670 CZT Quest Launches New Tests for Determining Hereditary Cancer Predictive Launches Test for Spine Deformities LabCorp® Introduces Epi proColon® Agena Rolls Out MassARRAY® Dx Rosetta Introduces Three New Diagnostic Offerings bioMérieux Rolls Out GENE-UP® Roche Introduces New cobas Range Quest Launches Dako's PD-L1 Complementary Diagnostic Test Quest Introduces Dako's PD-L1 Tests for KEYTRUDA® Clarient Rolls Out PD-L1 Test for KEYTRUDA® Pathway Unveils CancerIntercept Cepheid Unveils Xpert® Carba-R update Cepheid Launches GeneXpert® Omni AlphaImpactRx Introduces BrandImpactDx BioNTech AG Introduces MammaTyper® EKF Showcases Molecular Diagnostics Products Series Microbix Unveils New Molecular Diagnostics Range Roche Introduces cobas® Liat System Quest Unveils BRCAvantage Plus Cepheid Rolls Out Xpert® TV OpGen Introduces Acuitas MDRO Gene Test DaVita Introduces Molecular Diagnostic Testing Grifols Obtains CE-Marking for ID CORE XT Molecular Diagnostic Kit QIAGEN Rolls Out careHPV Test in India QIAGEN Gets PMA Approval from the US FDA for artus® CMV RGQ MDx Kit Alere Obtains FDA Approval for Alere i Influenza A and B Test Qiagen Obtains Approval from the US Health Regulators for Gene-Testing Kit Immucor Obtains the US FDA Approval for PreciseType HEA Test Biocartis Introduces Idylla Roche Introduces cobas 6800/8800 Systems Roche Unveils CINtec PLUS* Roche Rolls Out cobas® HIV-1 and cobas HCV assays 7. RECENT INDUSTRY ACTIVITY Bio-Techne to Acquire Advanced Cell Diagnostics Myriad Acquires Sividon Diagnostics Siemens Acquires Neo New Oncology Luminex to Acquire Nanosphere DiaSorin Completes Acquisition of Focus Diagnostics Avant Acquires Amarantus Diagnostics HTG to Collaborate With Bristol-Myers Squibb Miroculus to Acquire Kapplex Cepheid's Xpert® MRSA NxG Gets European Approval SpeeDx Collaborates with Goffin Molecular FDA Approves BD's Totalys CE Mark Approves BioFire Diagnostics' FilmArray® Thermo Fisher Acquires Affymetrix Qiagen Collaborates with Mirati BioGenex to Commence Operations from India Center Illumina Collaborates with investors to Launch GRAIL Thermo Fisher Collaborates with Karolinska Institute CE Mark Approves Aptima® HCV Quant Dx Assay by Hologic FDA Approves BioFire Diagnostics' FilmArray® ERBA Acquires Lumora Seegene Collaborates with BD Life Sciences MDxHealth to Acquire NovioGendix Quest's Simplexa HSV 1 & 2 Test Gets FDA 510(k) Approval Burning Rock Partners with Illumina GE's Low Dose CT Screening Approved by FDA Roche to Acquire GeneWEAVE BioSciences Cancer Genetics Acquires Response Genetics, Inc OpGen Acquires AdvanDx Hitachi Collaborates with QIAGEN OPKO Takes Over Bio-Reference Laboratories Sysmex Signs Agreement with IndivuTest CE Mark Approves Xpert® HIV-1 Qual by Cepheid and FIND Xpert® HCV Viral Load by Cepheid gets CE Mark Approval Rosetta Acquires CynoGen Microbix Signs Agreement with Microbiologics Cepheid Receives Emergency Use Authorization by FDA for Ebola Test Novigenix Acquires Colox® Roche Takes Over Signature Diagnostics CE Mark Approves QIAGEN's Circulating Tumor DNA Test Amarantus Completes Acquisition of DioGenix Aegis Acquires Diagnovus Empire Announces Acquisition of ID Labs OncoGxSelect Receives NJDH Approval Roche Takes Over Ariosa FDA Approves Xpert® Norovirus by Cepheid Cepheid's Xpert® Flu/RSV XC Gets FDA Approval Roche's cobas® Strep A Test Receives 510(k) Clearance PDI Takes Over RedPath Veracyte Acquires Allegro Diagnostics GTCR Takes Over XIFIN QIAGEN to Collaborate with AstraZeneca BD Collaborates with MD Anderson Cancer Center Roche Acquires IQuum Myriad to Acquire Crescendo Bioscience Co-Diagnostics Unveils Co-Dx bioMérieux Acquires BioFire Diagnostics Thermo Fisher Scientific Acquires Life Technologies Myriad Genetics Takes Over Crescendo Bioscience AUT University Collaborates with Roche Diagnostics Corgenix Medical Obtains NIH Grant to Advance Development of Ebola Rapid Diagnostic Test Kit Cepheid Collaborates with AstraZeneca, Cubist Pharmaceuticals and GSK B Braun US and CeGaT Join Forces to Establish B Braun CeGaT Provista Diagnostics Expands Exclusive License Agreement for Certain Biomarker and Autoantibody Technologies Veracyte and Fleury Partner to Offer the Afirma® Gene Expression Classifier Integrated Diagnostics Attracts Financing for Xpresys Lung Molecular Diagnostic Blood Test MDxHealth Enters into Agreement with Galaxy Health QIAGEN Acquires Exclusive Worldwide License to CALR Biomarker Zyomyx Obtains $7.5 Million from UNITAID to Launch MyT4 POC CD4 Test Human Longevity Inc. Commences its Operations Roche Takes Over IQuum Myriad Genetics and Sividon Diagnostics Ink Exclusive Co- Marketing Agreement 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 145 (including Divisions/Subsidiaries 162)
- The United States (99)
- Canada (2)
- Europe (50)
- - France (5)
- - Germany (11)
- - The United Kingdom (12)
- - Italy (2)
- - Spain (1)
- - Rest of Europe (19)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/p4hz9g/molecular Related Topics: In Vitro Diagnostics , Molecular Diagnostics
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
